0.04
+7.82%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About United Health Products
From its filings with the US Securities and Exchange Commission
United Health Products is based in Mesquite, Nevada and is incorporated in Nevada. Its shares trade on OTC under the ticker UEEC. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $0 and a net loss of $2.7m. At that date it held total assets of $316,698 and shareholders' equity of −$3.9m.
United Health Products, Inc. (“UHP”, “we” or the “Company”) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. Our gauze product, CelluSTAT®, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. We are in the process of seeking regulatory approval to sell our hemostatic gauze product line into the U.S. Class III and European CE Mark human surgical markets.
We are continuing on our path to seek FDA Premarket Approval (PMA) for our CelluSTAT Hemostatic Gauze products to implement our business strategy.
In March 2024, we submitted a full application for Premarket Approval to the FDA. The FDA responded in June 2024 with a “Deficiencies Letter” listing approximately 40 specific comments and requests for additional information covering the device description, sterility & shelf life, clinical & performance testing, and biocompatibility sections of the PMA application.
From September 23 through October 4, 2024, the FDA conducted a Bioresearch Monitoring Program (BIMO) Inspection of our records and procedures relating to our 2019 clinical study, following which the FDA delivered its Inspectional Observations on Form 483.
Quoted from its 10-K, filed 15 Apr 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 14 Feb 2007
- Employees
- 4
- Website
- unitedhealthproductsinc.com ↗
- Head office
- 526 COMMERCE CIRCLE, MESQUITE, NV, 89027
- Incorporated in
- NV
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Brian ThomChief Executive Officer, Interim Principal Financial Officer, Director, since 2020$198,000
- Mr. Robert DenserIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- United Health Products Inc (UHPI) has several strengths that contribute to its competitive advantage and market position. Firstly, the company specializes in manufacturing and distributing wound care products, which provides a focused and specialized approach to this particular market segment. This expertise allows UHPI to develop innovative and high-quality products that meet the specific needs of healthcare professionals and patients. Secondly, UHPI has established strong partnerships and collaborations with key stakeholders in the healthcare industry, including hospitals, clinics, and healthcare suppliers. These partnerships enhance UHPI's distribution capabilities and enable the company to reach a wide customer base, both domestically and internationally. Additionally, UHPI's products have been granted FDA clearances, which provide assurance to customers regarding the safety and efficacy of the products. This regulatory approval differentiates UHPI from competitors and enhances its credibility in the marketplace.
Weaknesses
- Despite its strengths, UHPI also faces certain weaknesses that could potentially hinder its growth and market performance. One weakness is the company's relatively small size and limited resources compared to larger competitors in the industry. This can pose challenges in terms of scalability, marketing budget, and research and development capabilities. Additionally, UHPI may face difficulty in penetrating highly competitive markets where established competitors already have strong brand recognition and customer loyalty. Building brand awareness and gaining market share in such environments can be a major challenge for the company.
Opportunities
- There are several opportunities that UHPI can capitalize on to further its growth and expand its market presence. One opportunity lies in the increasing demand for advanced wound care products, as the aging population and rising prevalence of chronic diseases drive the need for effective wound management solutions. UHPI can leverage its expertise and product innovation to tap into this growing market and gain a competitive advantage. Furthermore, UHPI can explore strategic partnerships and collaborations with healthcare institutions and organizations to expand its distribution network and enhance market penetration. By aligning with key stakeholders, UHPI can access new customer segments and geographies, increasing its market reach.
Threats
- UHPI faces certain threats that could impact its business operations and market position. One major threat is the presence of substitute products and alternative treatments for wound care. These substitutes may offer similar therapeutic benefits at lower costs or with different delivery mechanisms, potentially reducing the demand for UHPI's products. Additionally, regulatory changes and compliance requirements in the healthcare industry can pose threats to UHPI. Changes in government regulations or reimbursement policies can impact the pricing and accessibility of UHPI's products, affecting the company's financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.